Walmart sinks 9.4% after U.S. comparable sales slow
Walmart falls 9.4% after reporting adjusted EPS of $0.81 and revenue of $187.9 billion that topped consensus, while U.S. comparable sales rose 2.6% versus 3.8% expected and the company lifted full-year adjusted EPS guidance to $2.80-$2.87.
S. Treasury’s bond-buyback rescue lasted less than 24 hours, as long-term yields snapped back toward 20-month highs Thursday, weighing on stocks amid investor concerns that buybacks can’t offset heavy deficit financing, corporate debt issuance and sticky inflation. S. government.
26% — erasing almost the entire post-announcement decline. 2%. 8%, or roughly 430 points, to 53,033. The heaviest drag on the blue-chip index?
Walmart Inc. (NYSE: WMT ) — the stock cratered on its slowest domestic sales growth in six years. 62, its sharpest single-session decline in four years. S.
8% expected — the slowest domestic growth in six years — and the margin beat leaned heavily on tariff refunds. 87. 8% to 29,186. 39.
Bitcoin (CRYPTO: BTC) soared past $72,000, on pace for its strongest week since November 2024. 4%. 8%. 6%.
3%. 2% month-to-date as crude reprices the Hormuz blockade. 5%. 5%, the worst of the eleven groups.
7%. 5% on the back of farm-equipment earnings. 5% advance and is now up nearly 35% month-to-date. S.
S. 0%. Tempus AI Inc. 5 billion.
BTIG reiterated a Buy rating and lifted its price target to $80. 9 billion. 00 billion while calling 2026 the bottom of the ag equipment cycle. V.
0%, and fertilizer names CF Industries Holdings Inc. 9%. Crypto equities ripped for a second session. Strategy Inc.
7% and Circle Internet Group Inc. 3 billion short squeeze powered bitcoin past $72,000, with Trump’s meeting with major crypto executives adding fuel. Coinbase Global Inc. 7% and Bitmine Immersion Technologies Inc.
7%. Caris Life Sciences Inc. 0% gain. The company last reported on Aug.
1% advance in Illumina Inc. (NASDAQ: ILMN ). The Downside Moderna Inc. 3% and roughly $14 billion in market value one session after a 177% moonshot on the melanoma vaccine data.
Investors locked in gains and refocused on the $782 million second-quarter net loss and negative operating cash flow underneath the oncology story. X-Energy Inc. 7% and SOLV Energy Inc. 26% and by lingering doubts over AI capex durability that have dogged the group all month.
Oklo Inc. 8% alongside them. Karman Holdings Inc. 1%.
The move looks like sector-wide de-risking after Bessent signaled Washington will lean on economic rather than military pressure on Iran. AeroVironment Inc. 7%, Kratos Defense & Security Solutions Inc. 8% and Rocket Lab Corpor